New webinar series released by Guild

Guild Learning and Development, together with Novo Nordisk, has developed a new online module, ‘IDegAsp – a co-formulation insulin’.

The module consists of three short webinars, and focuses on the insulin formulation – its properties, safety and efficacy.

IDegAsp is available in Australia as Ryzodeg and comprises the ultra-long acting insulin, degludec, with the rapid-acting insulin, aspart, in one injection.

This learning activity has been accredited for one hour of Group 1 CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to one hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.

To enrol in this course, please visit:

Please contact Guild Learning and Development on 1800 049 056 or email for more information.

Must Read

SHPA and PSS sign new Memorandum of Understanding

The Society of Hospital Pharmacists of Australia (SHPA) and the Pharmacists’ Support Service (PSS) have signed a new Memorandum of Understanding. The signing of...